File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Micropulse Laser for the Treatment of Glaucoma: A Literature Review

TitleMicropulse Laser for the Treatment of Glaucoma: A Literature Review
Authors
KeywordsGlaucoma
Micropulse laser
Subthreshold laser
Laser trabeculoplasty
Micropulse trabeculoplasty
Micropulse transscleral cyclophotocoagulation
Issue Date2019
PublisherElsevier Inc. The Journal's web site is located at http://www.surveyophthalmol.com
Citation
Survey of Ophthalmology, 2019, v. 64 n. 4, p. 486-497 How to Cite?
AbstractGlaucoma, a progressive optic neuropathy, is the leading cause of irreversible blindness worldwide. Glaucoma patients are usually initially managed with medications and laser therapies, before more invasive ocular surgeries. For laser treatments of glaucoma, laser trabeculoplasty and laser transscleral cyclophotocoagulation lower the intraocular pressure (IOP) by increasing the aqueous outflow and decreasing the aqueous production, respectively. The development of a subthreshold laser technique, the micropulse laser, has been investigated as a potential alternative to traditional glaucoma laser procedures, with an aim to further decrease the risk of side effects without compromising the laser treatments’ efficacy. Few reviews have been done on the two current micropulse laser treatments for glaucoma - micropulse laser trabeculoplasty and micropulse transscleral cyclophotocoagulation. Hence, the purpose of this review was to assess the efficacy and safety of micropulse laser techniques in the treatment of glaucoma.
Persistent Identifierhttp://hdl.handle.net/10722/266492
ISSN
2021 Impact Factor: 6.197
2020 SCImago Journal Rankings: 2.131
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMa, A-
dc.contributor.authorYu, SWY-
dc.contributor.authorWong, JKW-
dc.date.accessioned2019-01-18T08:20:42Z-
dc.date.available2019-01-18T08:20:42Z-
dc.date.issued2019-
dc.identifier.citationSurvey of Ophthalmology, 2019, v. 64 n. 4, p. 486-497-
dc.identifier.issn0039-6257-
dc.identifier.urihttp://hdl.handle.net/10722/266492-
dc.description.abstractGlaucoma, a progressive optic neuropathy, is the leading cause of irreversible blindness worldwide. Glaucoma patients are usually initially managed with medications and laser therapies, before more invasive ocular surgeries. For laser treatments of glaucoma, laser trabeculoplasty and laser transscleral cyclophotocoagulation lower the intraocular pressure (IOP) by increasing the aqueous outflow and decreasing the aqueous production, respectively. The development of a subthreshold laser technique, the micropulse laser, has been investigated as a potential alternative to traditional glaucoma laser procedures, with an aim to further decrease the risk of side effects without compromising the laser treatments’ efficacy. Few reviews have been done on the two current micropulse laser treatments for glaucoma - micropulse laser trabeculoplasty and micropulse transscleral cyclophotocoagulation. Hence, the purpose of this review was to assess the efficacy and safety of micropulse laser techniques in the treatment of glaucoma.-
dc.languageeng-
dc.publisherElsevier Inc. The Journal's web site is located at http://www.surveyophthalmol.com-
dc.relation.ispartofSurvey of Ophthalmology-
dc.subjectGlaucoma-
dc.subjectMicropulse laser-
dc.subjectSubthreshold laser-
dc.subjectLaser trabeculoplasty-
dc.subjectMicropulse trabeculoplasty-
dc.subjectMicropulse transscleral cyclophotocoagulation-
dc.titleMicropulse Laser for the Treatment of Glaucoma: A Literature Review-
dc.typeArticle-
dc.identifier.emailWong, JKW: jwongkw@hku.hk-
dc.identifier.authorityWong, JKW=rp02294-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.survophthal.2019.01.001-
dc.identifier.pmid30639207-
dc.identifier.scopuseid_2-s2.0-85065132831-
dc.identifier.hkuros296730-
dc.identifier.volume64-
dc.identifier.issue4-
dc.identifier.spage486-
dc.identifier.epage497-
dc.identifier.isiWOS:000473557300005-
dc.publisher.placeUnited States-
dc.identifier.issnl0039-6257-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats